Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Skadden snaps up powerhouse trial team from collapsed Weil
Careers
The seven-partner team are some of the “most accomplished” IP trial lawyers in the country, bringing extensive experience in patent, trade secret and commercial disputes for major technology and life sciences companies.   19 November 2026
BMS appoints new trademarks lead as Elisabeth Stewart Bradley retires
Careers
The leadership change marks the end of Bradley’s 15-year tenure at BMS, during which she also served as INTA president for one year.   19 November 2026
Nominations open for third annual LSPN Awards USA
Regulation & Industry
The 2027 US awards in Boston features three new categories recognising AI innovation, in-house IP teams and cross-border patent litigation.   19 November 2026
Pharma
A heated dispute over Boehringer’s diabetes drug empagliflozin has ended in a split decision, with the judge drawing a sharp line between what a patent discloses and what can be inferred from it.   18 November 2026
In-house counsel
Conversations at AI & IP Europe in Brussels prove that in-house IP leaders who 'grasp the nettle'—such as Carola Lempke of AstraZeneca—are becoming essential to their company’s rollout of AI, says Tom Phillips.   18 November 2026
Biotech
A US judge tosses an antitrust lawsuit accusing Alexion of using sham patent litigation to delay competition to Soliris, finding that its favourable settlement with a rival undermined the claims.   17 November 2026
Careers
Following the collapse of Weil, Gotshal and Manges, the “standout” trial lawyer returns to Latham & Watkins, bringing deep experience of representing technology companies—including medtech—in complex disputes.   17 November 2026
Biotech
The Swiss pharma giant will work with a Taiwan-based biotech’s ADC platform technologies to develop next-generation cancer therapies in a deal worth potentially more than $2bn, including $30m upfront.   16 November 2026
Biotech
Curiox claims confidential information shared during talks about a potential business partnership was used to develop a competing cell preparation system within months, despite the South Korean company spending years developing its own technology.   13 November 2026
Pharma
Handing the pharma giant a major win in its feud with Pfizer and BioNTech, the UPC’s injunction reaches well beyond the court’s member states. But with an appeal still possible and parallel disputes playing out across the US and Europe, the fight is far from over.   12 November 2026